US Patent Issued to Domain Therapeutics on Jan. 20 for "Prostaglandin E 2 (PGE 2 ) EP 4 receptor antagonists" (French Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,779, issued on Jan. 20, was assigned to Domain Therapeutics (Illkirch-Graffenstaden, France).

"Prostaglandin E 2 (PGE 2 ) EP 4 receptor antagonists" was invented by Anne-Laure Blayo (Illkirch-Graffenstaden, France), Ismet Dorange (Illkirch-Graffenstaden, France), Gael Hommet (Illkirch-Graffenstaden, France), Baptiste Manteau (Illkirch-Graffenstaden, France), Stanislas Mayer (Illkirch-Graffenstaden, France) and Stephan Schann (Illkirch-Graffenstaden, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided he...